The semaglutide monthly results breakdown and tirzepatide first month results provide benchmarks for comparison
The results showed that in high risk patients with T2D liraglutide reduced the risk of MACE by 13% (primary endpoint included cardiovascular death, non-fatal myocardial infarction (MI), and non-fatal stroke) (37)
Semaglutide in patients with heart failure with preserved ejection fraction and obesity
Rare side effects include pancreatitis, acute kidney injury, worsening diabetes-related retinopathy and medullary thyroid cancer
But with the recent FDA approval of these drugs in pill form, the top brands are ubiquitous, and many patients are a little foggy on the best option for them
The way your body processes food and stores energy also changes, as semaglutide affects how your body uses food and stores energy, resulting in metabolic shifts